Pharming To Acquire Abliva And Mitochondrial Disease ‘Potential Blockbuster’ Asset

 
• By Andrew McConaghie
  
mitochondria
KL1333 targets mitochondria dysfunction • Source: Shutterstock

More from Deals

More from Therapy Areas